Discover the full record of transactions filed by Rickey James Paul, Chief Financial Officer. Officer active across 1 companies, notably ALPINE IMMUNE SCIENCES, INC.. Cumulatively, 2 disclosures have been logged. Total volume traded: €418k. The latest transaction was disclosed on 31 December 2021 — Cession. Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations
James Paul Rickey is the Senior Vice President and Chief Financial Officer of Alpine Immune Sciences, Inc. In this role, he is responsible for financial management and the overall strategy of the company. His expertise in the biopharmaceutical sector and ability to lead teams are valuable assets for Alpine Immune Sciences. James Rickey is committed to supporting the company's mission.